A robotic arm slowly approached a glass vial (vial) the size of a finger. It paused as if gauging the position, then firmly ...

The U.S. FDA's Center for Drug Evaluation and Research said on Wednesday it has accepted a letter of intent for ​an ...

ALNY teams up with Inceptive in a deal worth up to $2B, using AI models and proprietary RNAi data to speed drug discovery and ...

In late May 2026, Thermo Fisher Scientific showcased its new Thermo Scientific Orbitrap Tribrid Apex and Orbitrap Excedion ...

Pfizer is paying Innovent $650 million upfront to partner on cancer drug development, following Bristol Myers Squibb by ...

By Siddhi Mahatole June 2 (Reuters) - Shares of Fulcrum Therapeutics plunged 52% on Tuesday after the company said it would ...

Discover how quality-driven drug development and AI accelerate safer medicines, reduce risk, and improve patient outcomes.

In this week’s edition of InnovationRx, we look at a new AI drug development deal, a pill for sleep apnea, Commure’s $7 ...

From spaceflight to high-throughput studies, evidence supports greater use of organ chips, but regulatory ambiguity and ...

Big Pharma is pouring money into tech-devised treatments, but the verdict is out on whether they’ll actually work.

Clinical trials in China are getting attention at an international oncology gathering in Chicago. China’s surging biotechnology industry is fueling alarm that U.S. dominance in the field is waning.